Bioorganic & Medicinal Chemistry Letters 28 (2018) 1011–1019 Contents lists available at ScienceDirect Bioorganic & Medicinal Chemistry Letters journal homepage: www.elsevier.com/locate/bmcl Design, synthesis, and in vitro evaluation of quinolinyl analogues for a-synuclein aggregation a b a a b a c Xuyi Yue , Dhruva D. Dhavale , Junfeng Li , Zonghua Luo , Jialu Liu , Hao Yang , Robert H. Mach , b a,⇑ Paul T. Kotzbauer , Zhude Tu Department of Radiology, Washington University School of Medicine, St Louis, MO, United States Department of Neurology, Washington University School of Medicine, St Louis, MO, United States Department of Radiology, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA, United States article i nfo abstract Article history: Here we report the synthesis and in vitro evaluation of 25 new quinolinyl analogues for a-synuclein Received 6 January 2018 aggregates. Three lead compounds were subsequently labeled with carbon-11 or ﬂuorine-18 to directly Revised 9 February 2018 assess their potency in a direct radioactive competitive binding assay ng both a-synuclein ﬁbrils and tis- Accepted 14 February 2018 sue homogenates from Alzheimer’s disease (AD) cases. The modest binding afﬁnities of these three radi- Available online 16 February 2018 oligands toward a-synuclein were comparable
Bioorganic & Medicinal Chemistry Letters – Elsevier
Published: Apr 1, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.
All for just $49/month
Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.
Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.
It’s easy to organize your research with our built-in tools.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera